Implication of non-coding RNA-mediated ROCK1 regulation in various diseases

Zugehörigkeit
Department of Medical Genetics ,School of Medicine ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Ghafouri-Fard, Soudeh;
Zugehörigkeit
Faculty of Medicine ,Birjand University of Medical Sciences ,Birjand ,Iran
Poornajaf, Yadollah;
Zugehörigkeit
Department of Pharmacognosy ,College of Pharmacy ,Hawler Medical University ,Erbil ,Iraq
Hussen, Bashdar Mahmud;
Zugehörigkeit
Men’s Health and Reproductive Health Research Center ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Abak, Atefe;
Zugehörigkeit
Clinical Research Development Unit of Tabriz Valiasr Hospital ,Tabriz University of Medical Sciences ,Tabriz ,Iran
Shoorei, Hamed;
GND
1249707153
Zugehörigkeit
Institute of Human Genetics ,Jena University Hospital ,Jena ,Germany
Taheri, Mohammad;
Zugehörigkeit
Skull Base Research Center ,Loghman Hakim Hospital ,Shahid Beheshti University of Medical Sciences ,Tehran ,Iran
Sharifi, Guive

Rho Associated Coiled-Coil Containing Protein Kinase 1 (ROCK1) is a protein serine/threonine kinase which is activated upon binding with the GTP-bound form of Rho. This protein can modulate actin-myosin contraction and stability. Moreover, it has a crucial role in the regulation of cell polarity. Therefore, it participates in modulation of cell morphology, regulation of expression of genes, cell proliferation and differentiation, apoptotic processes as well as oncogenic processes. Recent studies have highlighted interactions between ROCK1 and several non-coding RNAs, namely microRNAs, circular RNAs and long non-coding RNAs. Such interactions can be a target of medications. In fact, it seems that the interactions are implicated in therapeutic response to several medications. In the current review, we aimed to explain the impact of these interactions in the pathoetiology of cancers as well as non-malignant disorders.

Zitieren

Zitierform:
Zitierform konnte nicht geladen werden.

Rechte

Rechteinhaber: Copyright © 2022 Ghafouri-Fard, Poornajaf, Hussen, Abak, Shoorei, Taheri and Sharifi.

Nutzung und Vervielfältigung: